what are the side effects of glp-1 drugs long term GLP-1 medications, commonly used for type 2 diabetes Struggling with GLP-1 therapy side
Description
The first incretin approved by the FDA in May 2005 was Byetta (exenatide)
doi: 10.2337/dc23-0231
WATER RESISTANT, CUTS THE HUNGER HORMONE
Source data are provided with this publication
References GLP-1 Key Facts
Dr Alan Moses, Novo's Senior VP, Global Chief Medical Officer was in London last week to showcase the company's pipeline, and told pharmaphorum that the firm is planning for decades of further drug development against the killer epidemic
